ARMP has been granted a new patent
Jun 26, 2024, 10:37 PM
10.65%
What does ARMP do
Armata Pharmaceuticals, Inc., a clinical-stage biotech company based in Los Angeles, focuses on developing bacteriophage therapies for antibiotic-resistant bacterial infections, including Pseudomonas aeruginosa and Staphylococcus aureus. The company employs 72 people and targets multiple indications with its candidates AP-PA02, AP-PA03, and AP-SA02.
ARMP filed a patent for "bacteriophage compositions for treating pseudomonas infection" on Thu, October 6, 2022. The patent was officially published on Thu, June 8, 2023.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
